Lexicon Pharmaceuticals | LXRX - Ordinary Share Capital


Lexicon Pharmaceuticals reported $363.47M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Acadia Pharmaceuticals USD 169.18M 470K Dec/2025
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Coherus Biosciences USD 121.16M 4.92M Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Illumina USD 152.8M 900K Dec/2025
Insmed USD 214.26M 1.67M Dec/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
J&J USD 2.41B 584K Sep/2025
Lexicon Pharmaceuticals USD 363.47M 67K Dec/2025
MacroGenics USD 63.32M 60K Dec/2025
MannKind USD 307.83M 806K Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Moderna USD 391M 2M Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Puma Biotechnology USD 5K 0 Jun/2024
Sarepta Therapeutics USD 104.96M 196K Dec/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
United Therapeutics USD 43.64M 740K Dec/2025
Vanda Pharmaceuticals USD 58K 0 Dec/2024